Submitted by Anonymous (not verified) on 5 September 2023 - 11:08
Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Breast Neoplasms;Ovarian Neoplasms;Multiple Myeloma;Sarcoma, Kaposi, Date of authorisation: 15/09/2022, Revision: 2, Status: Authorised
Source: